Literature DB >> 21726611

Up-regulation of cyclin D1 by JNK1/c-Jun is involved in tumorigenesis of human embryo lung fibroblast cells induced by a low concentration of arsenite.

Yuan Li1, Lu Shen, Hui Xu, Ying Pang, Yuan Xu, Min Ling, Jianwei Zhou, Xinru Wang, Qizhan Liu.   

Abstract

Inorganic arsenic, a ubiquitous environmental contaminant, is associated with an increased risk of cancer. There are several hypotheses regarding arsenic-induced carcinogenesis. The mechanism of action remains obscure, although hyper-proliferation of cells is involved. In the present study, the molecular mechanisms underlying the proliferation and malignant transformation of human embryo lung fibroblast (HELF) cells induced by a low concentration of arsenite were investigated. The results reveal that a low concentration of arsenite induces cell proliferation and promotes cell cycle transition from the G(1) to the S phase. Moreover, arsenite activates the JNK1/c-Jun signal pathway, but not JNK2, which up-regulates the expression of cyclin D1/CDK4 and phosphorylates the retinoblastoma (Rb) protein. Blocking of the JNK1/c-Jun signal pathway suppresses the increases of cyclin D1 expression and Rb phosphorylation, which attenuates cell proliferation, reduces the transition from the G1 to the S phase, and thereby inhibits the neoplastic transformation of HELF cells induced by a low concentration of arsenite. Thus, activation of the JNK1/c-Jun pathway up-regulates the expression of cyclin D1, which is involved in the tumorigenesis caused by a low concentration of arsenite.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726611     DOI: 10.1016/j.toxlet.2011.06.024

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  10 in total

Review 1.  Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Authors:  Rita Nahta; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Rafaela Andrade-Vieira; Sarah N Bay; Dustin G Brown; Gloria M Calaf; Robert C Castellino; Karine A Cohen-Solal; Annamaria Colacci; Nichola Cruickshanks; Paul Dent; Riccardo Di Fiore; Stefano Forte; Gary S Goldberg; Roslida A Hamid; Harini Krishnan; Dale W Laird; Ahmed Lasfar; Paola A Marignani; Lorenzo Memeo; Chiara Mondello; Christian C Naus; Richard Ponce-Cusi; Jayadev Raju; Debasish Roy; Rabindra Roy; Elizabeth P Ryan; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Renza Vento; Jan Vondráček; Mark Wade; Jordan Woodrick; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

2.  Regulation of cyclin D1 by arsenic and microRNA inhibits adipogenesis.

Authors:  Kevin Beezhold; Linda R Klei; Aaron Barchowsky
Journal:  Toxicol Lett       Date:  2016-12-05       Impact factor: 4.372

3.  Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer.

Authors:  Yan Li; Qi Wang; Ning Ning; Fanglan Tang; Yan Wang
Journal:  J Ovarian Res       Date:  2020-07-13       Impact factor: 4.234

4.  Akt Regulated Phosphorylation of GSK-3β/Cyclin D1, p21 and p27 Contributes to Cell Proliferation Through Cell Cycle Progression From G1 to S/G2M Phase in Low-Dose Arsenite Exposed HaCat Cells.

Authors:  Yao Chen; Xudan Liu; Huanhuan Wang; Shiyi Liu; Nannan Hu; Xin Li
Journal:  Front Pharmacol       Date:  2019-10-11       Impact factor: 5.810

5.  Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway.

Authors:  Zheng-Cai Jiang; Xiao-Jun Chen; Qi Zhou; Xiao-Hua Gong; Xiong Chen; Wen-Jun Wu
Journal:  Int J Oncol       Date:  2019-05-29       Impact factor: 5.650

6.  MicroRNA‑628‑5p inhibits cell proliferation and induces apoptosis in colorectal cancer through downregulating CCND1 expression levels.

Authors:  Fei Guo; Jun Xue
Journal:  Mol Med Rep       Date:  2020-01-16       Impact factor: 2.952

7.  The pivotal regulatory factor circBRWD1 inhibits arsenic exposure-induced lung cancer occurrence by binding mRNA and regulating its stability.

Authors:  Xiaofei Li; Sixian Chen; Xin Wang; Ruirui Zhang; Jialei Yang; Haotian Xu; Wanting He; Mingshuang Lai; Shuilian Wu; Aruo Nan
Journal:  Mol Ther Oncolytics       Date:  2022-08-23       Impact factor: 6.311

8.  Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation.

Authors:  Lu Shen; Min Ling; Yuan Li; Yuan Xu; Yun Zhou; Jing Ye; Ying Pang; Yue Zhao; Rongrong Jiang; Jianping Zhang; Qizhan Liu
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

9.  Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer.

Authors:  Hui Ji; Yuan Li; Fei Jiang; Xingxing Wang; Jianping Zhang; Jian Shen; Xiaojun Yang
Journal:  Cancer Sci       Date:  2014-11-05       Impact factor: 6.716

10.  Chronic arsenic trioxide exposure leads to enhanced aggressiveness via Met oncogene addiction in cancer cells.

Authors:  Kushtrim Kryeziu; Christine Pirker; Bernhard Englinger; Sushilla van Schoonhoven; Melanie Spitzwieser; Thomas Mohr; Wilfried Körner; Regina Weinmüllner; Koray Tav; Johannes Grillari; Margit Cichna-Markl; Walter Berger; Petra Heffeter
Journal:  Oncotarget       Date:  2016-05-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.